Osiris Therapeutics names new CEO — again
June 26, 2017 at 13:04 PM EDT
Linda Palczuk, 55, will start in the position July 10, replacing Interim CEO David A. Dresner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.